
The literature underscores the importance of genetic testing for mutations such as KRAS, NRAS, BRAF, and HER2 in the management of colorectal cancer. These genetic markers are essential for determining the appropriateness of targeted therapies, which can significantly influence treatment outcomes.
colorectal, treatment, her2, affect, kras, cancer, nras, mutations, braf
colorectal, treatment, her2, affect, kras, cancer, nras, mutations, braf
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
